BOTTI, ELISABETTA
 Distribuzione geografica
Continente #
NA - Nord America 8.769
AS - Asia 1.763
EU - Europa 1.338
SA - Sud America 239
AF - Africa 24
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 2
Totale 12.140
Nazione #
US - Stati Uniti d'America 8.716
SG - Singapore 718
CN - Cina 452
RU - Federazione Russa 238
HK - Hong Kong 197
BR - Brasile 192
IT - Italia 189
DE - Germania 183
IE - Irlanda 180
VN - Vietnam 169
UA - Ucraina 125
FR - Francia 117
GB - Regno Unito 63
KR - Corea 62
SE - Svezia 55
FI - Finlandia 53
PL - Polonia 49
JP - Giappone 46
CA - Canada 32
IN - India 25
BE - Belgio 18
BD - Bangladesh 17
AR - Argentina 16
NL - Olanda 15
MX - Messico 14
EC - Ecuador 11
ES - Italia 11
TR - Turchia 10
AT - Austria 9
IQ - Iraq 9
ID - Indonesia 7
UZ - Uzbekistan 7
CL - Cile 5
CZ - Repubblica Ceca 5
KG - Kirghizistan 5
ZA - Sudafrica 5
CO - Colombia 4
DK - Danimarca 4
EU - Europa 4
JO - Giordania 4
KE - Kenya 4
MA - Marocco 4
PH - Filippine 4
PK - Pakistan 4
PY - Paraguay 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
EG - Egitto 3
IL - Israele 3
LT - Lituania 3
MD - Moldavia 3
MY - Malesia 3
RO - Romania 3
RS - Serbia 3
TH - Thailandia 3
AZ - Azerbaigian 2
CY - Cipro 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
ET - Etiopia 2
HR - Croazia 2
HU - Ungheria 2
NP - Nepal 2
OM - Oman 2
PE - Perù 2
PT - Portogallo 2
VC - Saint Vincent e Grenadine 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
AL - Albania 1
AM - Armenia 1
AU - Australia 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CU - Cuba 1
GA - Gabon 1
GR - Grecia 1
HN - Honduras 1
IR - Iran 1
LK - Sri Lanka 1
MO - Macao, regione amministrativa speciale della Cina 1
NG - Nigeria 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
SA - Arabia Saudita 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
Totale 12.140
Città #
Wilmington 1.814
Houston 1.791
Woodbridge 1.411
Fairfield 489
Singapore 433
Chandler 422
Ann Arbor 295
Ashburn 290
Seattle 222
Beijing 206
Hong Kong 191
San Jose 181
Cambridge 176
Dublin 165
Medford 124
Dearborn 119
New York 101
Jacksonville 84
The Dalles 70
Rome 68
Santa Clara 63
Los Angeles 61
Lawrence 58
Lauterbourg 47
Hanoi 46
Ho Chi Minh City 44
Tokyo 42
Council Bluffs 41
Dallas 41
Moscow 39
Kraków 35
Helsinki 33
Munich 31
San Diego 31
São Paulo 29
Buffalo 28
Turin 20
Redwood City 17
Boardman 16
Brussels 16
Guangzhou 16
Chicago 12
Nuremberg 12
Shanghai 12
Zhengzhou 12
Atlanta 11
Da Nang 11
Nanjing 11
Kunming 10
Montreal 10
Warsaw 10
Denver 9
London 9
Manchester 9
Milan 9
Orem 9
Redondo Beach 9
Stockholm 9
Chennai 8
Mülheim 8
Toronto 8
Brooklyn 7
Hefei 7
Jinan 7
Menlo Park 7
Norwalk 7
Paris 7
Poplar 7
San Francisco 7
Wuhan 7
Frankfurt am Main 6
Mountain View 6
San Mateo 6
Amsterdam 5
Curitiba 5
Falls Church 5
Hounslow 5
Nha Trang 5
North Bergen 5
Phoenix 5
Pune 5
Quito 5
Saint Louis 5
Salt Lake City 5
Utrecht 5
Vancouver 5
Amman 4
Ankara 4
Biên Hòa 4
Boston 4
Bắc Giang 4
Cagliari 4
Cangzhou 4
Casarile 4
Centrale 4
Chengdu 4
Columbus 4
Dhaka 4
Espoo 4
Genoa 4
Totale 9.806
Nome #
Sox2 is not required for melanomagenesis, melanoma growth and melanoma metastasis in vivo 552
Functionalized gold nanoparticles for topical delivery of methotrexate for the possible treatment of psoriasis 522
Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis 495
IL-21 Promotes Skin Recruitment of CD4+ Cells and Drives IFN- -Dependent Epidermal Hyperplasia 479
IL-21 in the pathogenesis and treatment of skin diseases 442
Efficacy of short-term cyclosporine treatment to control psoriasis-related events during efalizumab therapy 438
Psoriasis, from pathogenesis to therapeutic strategies: IL-21 as a novel potential therapeutic target 437
S100A8/A9 in psoriatic plaques from patients with psoriatic arthritis 409
The tumor suppressor activity of IKK alpha in stratified epithelia is exerted in part via the TGF-beta anti proliferative pathway 406
Clindamycin versus clindamycin plus rifampicin in Hidradenitis Suppurativa treatment: clinical and ultrasound observations 389
Severe erytrodermic psoriasis in child twins: From clinical-pathological diagnosis to treatment of choice through genetic analyses: Two case reports 380
Anti-LL37 antibodies are present in psoriatic arthritis (PsA) patients: New biomarkers in PsA 357
IL-21, a new player in pathogenesis of psoriasis 354
Effects of topical methotrexate loaded gold nanoparticle in cutaneous inflammatory mouse model 343
CXCL4 assembles DNA into liquid crystalline complexes to amplify TLR9-mediated interferon-α production in systemic sclerosis 339
null 287
Long-term efficacy and safety of adalimumab on a severe case of Hidradenitis Suppurativa 287
Bowel-associated dermatosis arthritis syndrome and palisading neutrophilic granulomatous dermatitis as presentation of ulcerative colitis 257
A regulatory feedback loop involving p63 and IRF6 links the pathogenesis of 2 genetically different human ectodermal dysplasias 214
Cutaneous mastocytosis: a dermatological perspective 201
Native/citrullinated LL37-specific T-cells help autoantibody production in Systemic Lupus Erythematosus 183
The combined role of clinical, reflectance confocal microscopy and dermoscopy applied to chronic discoid cutaneous lupus and subacutus lupus erythematosus: a case series and literature review 182
Detection of adalimumab and anti-adalimumab levels by ELISA: clinical considerations 176
Efficacy of efalizumab in psoriasis patients previously treated with tumour necrosis factor blockers 175
Vulvar basal cell carcinoma, so rare? 161
Long-term treatment of plaque psoriasis with efalizumab: an Italian experience 158
Developmental factor IRF6 exhibits tumor suppressor activity in squamous cell carcinomas 150
Allele-specific cytokine responses at the HLA-C locus: Implications for psoriasis 144
Genetic markers predictive of clinical response to biological drugs in psoriasis. 144
The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis 142
Nanomedicine in dermatology: Benefits and emerging applications 142
Confocal, wide band spectral reflection microscope, and relevant spectral imaging method 141
Pharmacogenetics of psoriasis: HLA-Cw6 but not LCE3B/3C deletion nor TNFAIP3 polymorphism predisposes to clinical response to interleukin 12/23 blocker ustekinumab 139
Suicide risk and psychiatric comorbidity in patients with psoriasis. 138
Dimethylfumarate efficacy and safety in palmoplantar psoriasis patient affected by hepatitis b and depression: A case report 137
Investigating the expression of the susceptibility allele HLA-Cw6 in psoriasis using a specific single chain fragment antibody 135
Genetic variations in IL6 and IL12B decreasing the risk for psoriasis 133
Patients with moderate to severe plaque psoriasis: One year after the European medicines agency recommendation of efalizumab suspension 131
p53 promuove la progressione tumorale nelle cellule di melamona resistenti agli inibitori di BRAF 130
IL12B (p40) Gene Polymorphisms Contribute to Ustekinumab Response Prediction in Psoriasis 128
Etanercept reverses downregulation of inhibitor of nuclear factor kappa-B kinase subunit alpha (IKKa) in psoriasis 123
HLA-Cw6 allele confers sensitivity to efalizumab treatment in psoriasis 118
Targeted therapy in nonmelanoma skin cancers 114
Assessing the expression of HLA-Cw6 using specific single chain antibody (scFv) 112
TRIM8 and p53: Making the right decision 106
Living matter observations with a novel hyperspectral supercontinuum confocal microscope for VIS to near-IR reflectance spectroscopy 104
Programmed cell death in the skin 101
Label-free and non-invasive discrimination of HaCaT and melanoma cells in a co-culture model by hyperspectral confocal reflectance microscopy 93
A Longitudinal Multiinstitutional Study of Vulvar Lichen Sclerosus: From Childhood to Perimenopause 90
Cw6 but not allele LCE3C_LCE3B deletion confers sensitivity to ustekinumab treatment in psoriasis 90
Next generation sequencing technology to explore anti-inflammatory activity of IKKa in psoriasis 84
Potential Role of Cytochrome c and Tryptase in Psoriasis and Psoriatic Arthritis Pathogenesis: Focus on Resistance to Apoptosis and Oxidative Stress 82
Human leucocyte antigen Cw6 predisposes to clinical response to the inlterleukin-12/23 blocker ustekinumab: results of long-term treatment 80
Genetic variations in IL6 and IL12B as protective markers for psoriasis 70
Use of brodalumab for the treatment of chronic plaque psoriasis: a one-year real-life study in the Lazio region, Italy 70
TP63 and TP73 in cancer, an unresolved "family" puzzle of complexity, redundancy and hierarchy 69
HLACw6 predisposes to clinical response to IL12/23 blocker ustekinumab: Results of short- and long-term treatment in anti-TNF naïve patients 68
Genetic variati ons in IL6 and IL12B as protecti ve markers for psoriasis Abstracts of the 2013 International Investigative Dermatology Meeting. May 8-11, 2013. Edinburgh, Scotland, United Kingdom 66
HLA-C*06:02 allele can influence clinical efficacy of certolizumab pegol? 65
Usefulness of topical imiquimod 3.75% in cytokeratin 7 positive extramammary paget disease of the vulva: towards personalized therapy 60
Potential role of HLA-Cw6 in clinical response to anti-tumour necrosis factor alpha and t-cell targeting agents in psoriasis patients 57
Totale 12.379
Categoria #
all - tutte 37.294
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.294


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021197 0 0 0 0 0 0 0 0 0 83 93 21
2021/2022570 23 62 17 23 18 36 45 23 38 53 55 177
2022/2023853 93 82 73 109 56 211 58 43 82 6 32 8
2023/2024316 34 7 19 7 33 95 12 29 4 8 9 59
2024/20251.197 66 244 123 97 13 75 115 58 82 105 80 139
2025/20262.051 180 104 259 231 221 83 331 215 230 197 0 0
Totale 12.379